New Advances in Nanomaterial-Based Antiviral Strategies

被引：13
作者：
Xu, Xican [1 ]
Zhang, Jin [1 ]
Liu, Shuang [1 ]
Wang, Chaohui [1 ]
Wang, Hongyu [1 ]
Fan, Huahao [2 ]
Tong, Yigang [2 ]
Liu, Huiyu [1 ]
Zhou, Dongsheng [3 ]
机构：
[1] Beijing Univ Chem Technol, Beijing Adv Innovat Ctr Soft Matter Sci & Engn, State Key Lab Organ Inorgan Composites,Beijing Ke, Beijing Lab Biomed Mat,Bionanomat & Translat Engn, Beijing 100029, Peoples R China
[2] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Adv Innovat Ctr Soft Matter Sci & Engn BA, Beijing 100029, Peoples R China
[3] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China
来源：
SMALL STRUCTURES | 2022年 / 3卷 / 07期
基金：
中国国家自然科学基金;
关键词：
antiviral therapy; COVID-19; nanocarriers; nanodrugs; nanovaccines; H1N1; INFLUENZA-VIRUS; SILVER NANOPARTICLES; GRAPHENE OXIDE; GOLD NANOPARTICLES; BETA-CYCLODEXTRIN; RIBAVIRIN PRODRUG; HIV-1; PROTEASE; INFLEXAL(R) V; IN-VITRO; INHIBITION;
D O I：
10.1002/sstr.202200021
中图分类号：
O64 [物理化学（理论化学）、化学物理学];
学科分类号：
070304 ; 081704 ;
摘要：
The ongoing coronavirus disease 2019 (COVID-19) pandemic and other major viral infectious diseases have become a significant threat to people's life and economic/social development. In recent years, with the development of nanotechnology, nanomaterial-based antiviral agents have been extensively studied. However, the clinical applications of antiviral nanomaterials are still limited. Herein, the recent advances in nanomaterial-based antiviral strategies, mainly including antiviral nanodrugs, drug nanocarriers, and nanovaccines, are summarized. The clinical challenges and prospects of nanomaterial-based antiviral strategies are also discussed.
引用
收藏
页数：19
相关论文
共 160 条
[1]   Virucidal Action Against Avian Influenza H5N1 Virus and Immunomodulatory Effects of Nanoformulations Consisting of Mesoporous Silica Nanoparticles Loaded with Natural Prodrugs [J].
AbouAitah, Khaled ;
Swiderska-Sroda, Anna ;
Kandeil, Ahmed ;
Salman, Asmaa ;
Wojnarowicz, Jacek ;
Ali, Mohamed A. ;
Opalinska, Agnieszka ;
Gierlotka, Stanislaw ;
Ciach, Tomasz ;
Lojkowski, Witold .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 :5181-5202
[2]   Antiviral drug discovery: preparing for the next pandemic [J].
Adamson, Catherine S. ;
Chibale, Kelly ;
Goss, Rebecca J. M. ;
Jaspars, Marcel ;
Newman, David J. ;
Dorrington, Rosemary A. .
CHEMICAL SOCIETY REVIEWS, 2021, 50 (06) :3647-3655
[3]   Assessment of Ocular Pharmacokinetics and Safety of Ganciclovir Loaded Nanoformulations [J].
Akhter, Sohail ;
Talegaonkar, Sushama ;
Khan, Zeenat I. ;
Jain, Gaurav K. ;
Khar, Roop K. ;
Ahmed, Farhan J. .
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2011, 7 (01) :144-145
[4]   Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir [J].
Al-Dhubiab, Bandar E. ;
Nair, Anroop B. ;
Kumria, Rachna ;
Attimarad, Mahesh ;
Harsha, Sree .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2015, 136 :878-884
[5]   The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms [J].
Alanagreh, Lo'ai ;
Alzoughool, Foad ;
Atoum, Manar .
PATHOGENS, 2020, 9 (05)
[6]  
[Anonymous], BRIT DENT J
[7]   Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review [J].
Asadi, Khatereh ;
Gholami, Ahmad .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 182 :648-658
[8]   Green synthesis and evaluation of silver nanoparticles as adjuvant in rabies veterinary vaccine [J].
Asgary, Vahid ;
Shoari, Alireza ;
Baghbani-Arani, Fahimeh ;
Shandiz, Seyed Ataollah Sadat ;
Khosravy, Mohammad Sadeq ;
Janani, Alireza ;
Bigdeli, Razieh ;
Bashar, Rouzbeh ;
Cohan, Reza Ahangari .
International Journal of Nanomedicine, 2016, 11 :3597-3605
[9]   Engineering and evaluation of amyloid assemblies as a nanovaccine against the Chikungunya virus [J].
Babych, Margaryta ;
Bertheau-Mailhot, Genevieve ;
Zottig, Ximena ;
Dion, Jessica ;
Gauthier, Laurie ;
Archambault, Denis ;
Bourgault, Steve .
NANOSCALE, 2018, 10 (41) :19547-19556
[10]   Light-activated nanotube-porphyrin conjugates as effective antiviral agents [J].
Banerjee, Indrani ;
Douaisi, Marc P. ;
Mondal, Dhananjoy ;
Kane, Ravi S. .
NANOTECHNOLOGY, 2012, 23 (10)
12345678910